Apotex Strengthens Osteoporosis Care in Canada with Health Canada’s Approval of DENOZA™, a Denosumab Biosimilar

B TORONTO, April 7, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global pharmaceutical company, today announced that Health Canada has…
posteditor
posteditor
Articles: 16137

Other News